Skip to main content
. 2019 Jan 22;12:721–732. doi: 10.2147/OTT.S190432

Figure 5.

Figure 5

The proliferation of 1,25-(OH)2D3-treated breast cancer cells was abrogated by overexpression of Ras.

Notes: Breast cancer cells were treated with 1,25-(OH)2D3 alone or together with the overexpression of Ras by using plasmid for 48 hours. (A) The expression of Ras protein in MCF-7 and MDA-MB-453 cells transfected with Ras-overexpressing plasmids was determined by Western blotting after the cells were treated for 48 hours. (B) The CCK-8 assay was used to determine the cell proliferation of MCF-7 cells every 24 hours for 2 days. (C) The CCK-8 assay was used to determine the cell proliferation of MDA-MB-453 cells every 24 hours for 2 days. (D) The expression of Ki67 protein in MCF-7 cells was determined by Western blotting after the cells were treated for 48 hours. (E) The expression of Ki67 protein in MDA-MB-453 cells was determined by Western blotting after the cells were treated for 48 hours. Error bars represent the SD. **P<0.01 vs Control, #P<0.05 vs 0.1 µm.

Abbreviations: 1,25-(OH)2D3, 1,25-dihydroxy vitamin D3; CCK-8, cell counting kit-8.